Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

JUdicious Surveillance for Trastuzumab Induced Cardiotoxicity in the First Year (JUSTIFY): a Randomized Controlled Trial

NCT06930521 is registered in ClinicalTrials.gov with Women's College Hospital as lead sponsor.

NCT NCT06930521
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06930521 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
JUdicious Surveillance for Trastuzumab Induced Cardiotoxicity in the First Year (JUSTIFY): a Randomized Controlled Trial
Lead sponsor
Women's College Hospital
Phase
Not applicable
Overall status
Recruiting
Start date
April 22, 2026
Completion date
June 30, 2033
Enrollment
300 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer, breast cancer early stage breast cancer (stage 1-3), cardio-oncology, cardiovascular health, circulatory and respiratory health, clinical and translational cardiovascular sciences, health services and systems - healthcare effectiveness & outcomes